Receives IDE Approval from U.S. FDA to Initiate Clinical Trial of the SHUNT Liver Diagnostic Kit
HepQuant Receives IDE Approval from U.S. FDA to Initiate Clinical Trial of the SHUNT Liver Diagnostic Kit SAN FRANCISCO (Nov. 9, 2018) – While attending The Liver Meeting® 2018, HepQuant, LLC, a Greenwood Village, Colorado-based company with a unique, patented and patent-pending technology for evaluating the liver in patients with chronic…
Sean Bundy Appointed Director of Regulatory and Quality Affairs
HepQuant Appoints Sean Bundy Director of Regulatory & Quality Affairs Bringing 20 Years in Medical Device and Diagnostics Regulatory and Quality Experience DENVER (Aug. 2, 2018) — HepQuant, LLC, a Greenwood Village, Colo.-based company with a unique, patented and patent-pending technology for evaluating the liver in patients with chronic liver disease,…
HepQuant Chosen to Advance to InnoSTARS Semifinals in China
HepQuant Selected as a Semifinalist for 2018 InnoSTARS Competition to be Held in China DENVER (May 9, 2018) — HepQuant, LLC, a Greenwood Village, Colo.-based company with a unique, patented and patent-pending technology for evaluating the liver in patients with chronic liver disease, announced today that the company has been named…
HepQuant a Finalist for InnoSTARS Denver Competition
HepQuant a Finalist for 2018 InnoSTARS Denver Competition DENVER (April 24, 2018) — HepQuant, LLC, a Greenwood Village, Colo.-based company with a unique, patented and patent-pending technology for evaluating the liver in patients with chronic liver disease, announced today that the company has been named a finalist for the 2018 InnoSTARS Denver…
HepQuant and CTI Clinical Trial and Consulting Services Announce First Patient Enrolled in Liver Disease Diagnostic Trial
HepQuant and CTI Clinical Trial and Consulting Services Announce First Patient Enrolled in Liver Disease Diagnostic Trial FOR IMMEDIATE RELEASE [Covington, KY ~ January 25, 2018] HepQuant, LLC, a Greenwood Village, Colorado-based company with a unique, patented and patent-pending technology for evaluating the liver in patients with chronic liver disease…
HepQuant to Present Poster as Finalist at RESI San Francisco Innovation Challenge
HepQuant to Present Poster as a Finalist in the RESI San Francisco Innovation Challenge 2018 DENVER (January 2nd, 2017) — HepQuant, LLC, a Greenwood Village, Colorado-based company with a unique, patented and patent-pending technology for evaluating the liver in patients with chronic liver disease, today announced it will present a…
HepQuant to Present at the 10th Annual Biotech Showcase
HepQuant to Present at 10th Annual Biotech Showcase Senior Executives Will Also Attend the J.P. Morgan Healthcare Conference DENVER (December 13th, 2017) — HepQuant, LLC, a Greenwood Village, Colo.-based company with a unique, patented and patent-pending technology for evaluating the liver in patients with chronic liver disease, today announced it…
HepQuant Presents at Rocky Mountain Life Science Investor and Partnering Conference
HepQuant Presents at the 2017 Rocky Mountain Life Science Investor and Partnering Conference DENVER (October 12th, 2017) — HepQuant, LLC, a Greenwood Village, Colo.-based company with a unique, patented and patent-pending technology for evaluating the liver in patients with chronic liver disease, today announced it presented at the 2017 Rocky Mountain…
HepQuant holding its 2017 Scientific Advisory Board Meeting in Washington D.C. on Saturday, October 21st
HepQuant to Hold 2017 Scientific Advisory Board October 21st in Washington, DC DENVER (August 31, 2017) — HepQuant, LLC, a diagnostics company, located in Greenwood Village, CO with unique, patented and patent-pending technology for evaluating the liver in patients with chronic liver disease, today announced today announced it will be holding…
HepQuant to Sponsor its First Clinical Study
HepQuant to Sponsor its First Clinical Study Utilizing 3 Investigational Device Exemptions (IDEs) in Clinical Study of Patients with Alcoholic Hepatitis, NASH F3, NASH F4 DENVER (Sep. 28, 2017) — HepQuant, LLC, a Greenwood Village, Colorado-based company with a unique, patented and patent-pending technology for evaluating the liver in patients…